scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0168-8278(96)80191-7 |
P698 | PubMed publication ID | 8834030 |
P2093 | author name string | F Marumo | |
S Sakamoto | |||
T Ikeda | |||
C Sato | |||
F Kobayashi | |||
O Noguchi | |||
S Tozuka | |||
P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
Serum bilirubin: a prognostic factor in primary biliary cirrhosis | Q34494336 | ||
The route of secretion of procollagen. The influence of αα′-bipyridyl, colchicine and antimycin A on the secretory process in embryonic-chick tendon and cartilage cells | Q39106303 | ||
D-penicillamine for primary biliary cirrhosis. | Q42072011 | ||
A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
Randomized trial of chlorambucil for primary biliary cirrhosis. | Q44093311 | ||
The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis | Q45024371 | ||
Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
Ultrasonographic Determination of the Splenic Size and Its Clinical Usefulness in Various Liver Diseases | Q47350583 | ||
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
Lysosomes and Gout | Q59084997 | ||
The action of colchicine in acute gouty arthritis | Q67348692 | ||
Evaluation of colchicine therapy in primary biliary cirrhosis | Q68139571 | ||
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis | Q68505504 | ||
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report | Q69401293 | ||
A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss | Q69721905 | ||
Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
The natural history of primary biliary cirrhosis | Q70258300 | ||
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC | Q72789964 | ||
Cytosine arabinoside in herpes zoster | Q93731462 | ||
P433 | issue | 1 | |
P921 | main subject | (S)-(−)-colchicine | Q326224 |
primary biliary cholangitis | Q1072420 | ||
P304 | page(s) | 88-94 | |
P577 | publication date | 1996-01-01 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study | |
P478 | volume | 24 |
Q53950071 | Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. |
Q77716502 | Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis |
Q24186361 | Colchicine for prevention of cardiovascular events |
Q24247122 | Colchicine for primary biliary cirrhosis |
Q24248630 | Colchicine for primary biliary cirrhosis |
Q53352157 | Colchicine: 1998 update. |
Q35068031 | Current management of primary biliary cirrhosis and primary sclerosing cholangitis |
Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
Q62072028 | Enhanced bile formation induced by experimental dicrocoeliosis in the hamster |
Q43807982 | Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? |
Q35960781 | Management of primary biliary cirrhosis and autoimmune cholangitis |
Q81724957 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis |
Q26824664 | Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis |
Q28087211 | Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis |
Q38738566 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. |
Q34210604 | Primary biliary cirrhosis and primary sclerosing cholangitis |
Q35573929 | Primary biliary cirrhosis: specific treatment |
Q44736205 | Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy |
Q34182672 | Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis |
Q24202184 | Ursodeoxycholic acid for primary biliary cirrhosis |
Q24241945 | Ursodeoxycholic acid for primary biliary cirrhosis |
Search more.